Rise in organ failure events to upsurge the HLA typing transplant market

Rise in organ failure events to upsurge the HLA typing transplant market

Human leukocyte antigen (HLA) is situated in the chromosome 6 that is found in nearly every nucleated cell. The HLA system consists of a complex group of genes that direct the immune reaction via confirmation of non-self and self-antigens, which further can result in rejection of graft, HLA typing, also called as tissue typing, is needed widely to study rejection of graft due to tissue, bone marrow, blood cell, and organ transplantation.

The growth of the HLA typing transplant market is mainly influenced by the factors such as technological advancements; the growing number of stem cell, solid organ, & soft tissue transplantations; and elevated funding, public–private investments, and research grants. Below mentioned are few factors discussed in detail.

Rise in organ failure events to upsurge the HLA typing transplant market

Growing incidence of organ failure

The demand for organs and tissue such as heart, bone marrow, kidney, lungs, and liver is extremely high across the world. The rising rate of alcohol consumption, drug intake, and unhealthy lifestyles & food habits are the leading factors of organ failure. Apart from this, the increase in elderly population leads to an elevated requirement for organs for transplantation.

Acquisition of small hospitals by Tier 1 hospitals

The rising possession of small hospitals has aided to amplify organ transplantation, transplant diagnosis, and wound care in the market that has indirectly supported the market growth. Tier 1 hospitals get hold of small specialized hospitals that assists to tutor the physicians, nurses, and healthcare staff. It also aids to fulfill the rising patient requirements by offering a series of patient monitoring tools.

Technological advances in organ transplantation

The development of novel and enhanced transplantation products, such as tissue typing technology, surgical medical instruments, and organ preservation solution for specific organs fuels the growth of the market. Moreover, the improvements in the polymerase chain reaction, such as improved assay development and advancements in system design, offer high efficiency and precision in tissue typing. The development in transplant technology elevates patient safety and keeps an eye on organ functioning. This eventually augments the post-transplant healing period.

On the other hand, the high device price linked to PCR & NGS-based devices and inadequate medical compensations for organ transplantation & donation procedures may hamper the growth of the market.

Reply